The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA ≤ 10 ng/ml and T1c,2a: implications for patient selection for prostate-only therapy

This publication has 10 references indexed in Scilit:

• Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
  JAMA, 1998
• A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1998
• Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml
  International Journal of Radiation Oncology*Biology*Physics, 1997
• State T1–2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
  Journal of Urology, 1995
• Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
  Journal of Urology, 1995
• Correlation with Grade in 316 Matched Prostatectomies
  The American Journal of Surgical Pathology, 1994
• The Accuracy of Diagnostic Biopsy Specimens in Predicting Tumor Grades by Gleason’s Classification of Radical Prostatectomy Specimens
  Journal of Urology, 1984
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958